Results of treatment and survival of 231 patients with stage III bronchogenic carcinoma
Ain-Shams Medical Journal. 1989; 40 (1): 123-130
in English
| IMEMR
| ID: emr-11944
ABSTRACT
Two hundred and thirty one patients with stage III Bronchogenic Carcinoma had been studied at NEMROCK [1974 1985]. 82% of patients had non small cell lung cancer, while 18% of patients had small cell lung cancer. 29% of patients received radiation therapy alone and 30% of patients received chemotherapy, while 41% of patients received combination of chemo and radiotherapy complete remission after treatment was obtained in 19.5% of patients, all of them received combined modality of treatment with a mean duration of response 10.5 +/- 11 months. There was a better 18 months survival for the patients received combined treatment modality as compared with other groups, and the difference was significant P < 0. 05]
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Survival Rate
/
Treatment Outcome
/
Chemotherapy, Adjuvant
/
Combined Modality Therapy
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Ain-Shams Med. J.
Year:
1989
Similar
MEDLINE
...
LILACS
LIS